Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Clinical trial NCT01031381 · COMPLETED
Trial details
- NCT number
- NCT01031381
- Sponsor
- University of Pittsburgh
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2014-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.